Ming Xian - Nov 8, 2022 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Nov 8, 2022
Transactions value $
$2,107
Form type
4
Date filed
2/9/2023, 08:06 PM
Previous filing
Aug 10, 2022
Next filing
May 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MED Restricted Stock Units (cash settled) Award $1.05K +9.78 +0.5% $106.93 1.96K Nov 8, 2022 Common Stock 9.78 Direct F1, F2
transaction MED Restricted Stock Units (cash settled) Award $1.06K +9.23 +0.47% $114.97 1.97K Feb 7, 2023 Common Stock 9.23 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.
F2 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.